SHARE
Epigenetics Market

Epigenetics is a biological process to control gene expression by altering the chromatin structure. Genes which are going to be expressed are associated with accessible chromatin regions, whereas silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic changes on the basis of which epigenetic therapy develops.

Technavio’s analysts forecast the global epigenetics market to grow at a CAGR of 13.22% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global epigenetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of epigenetics products.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Epigenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Abcam
• Bio-Rad Laboratories
• Merck
• Thermo Fisher Scientific

Other prominent vendors
• Active Motif
• BellBrook Labs
• BioVision
• CELGENE
• Cisbio.com
• Diagenode
• Epizyme
• Illumina
• New England Biolabs
• Novartis
• QIAGEN

Inquire for Discount Report at: https://www.marketinsightsreports.com/reports/08187845/global-epigenetics-market-2017-to-2021/discount

Market driver
• Increasing prevalence of cancer
• For a full, detailed list, view our report

Market challenge
• Difficulty in finding predictive epigenetic biomarker
• For a full, detailed list, view our report

Market trend
• Increasing demand for personalized medicine
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Market driver
• Increasing prevalence of cancer
• For a full, detailed list, view our report

Market challenge
• Difficulty in finding predictive epigenetic biomarker
• For a full, detailed list, view our report

Market trend
• Increasing demand for personalized medicine
• For a full, detailed list, view our report
 

Order for Full Report at: https://www.marketinsightsreports.com/report/purchase/08187845?mode=su

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Announces the Publication of its Research Report – Global Epigenetics Market 2017-2021
Technavio recognizes the following companies as the key players in the global epigenetics market: Abcam, Bio-Rad Laboratories, Merck, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Active Motif, BellBrook Labs, BioVision, CELGENE, Cisbio.com, Diagenode, Epizyme, Illumina, New England Biolabs, Novartis, and QIAGEN.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing demand for personalized medicine. The demand for personalized medicine is increasing and is expected to grow in future with a CAGR of more than 10%. The development of whole genome technology, companion diagnostics, and the growing number of retail clinics are some reasons for its growth.”

According to the report, one driver in the market is increasing prevalence of cancer. Epigenetic mechanisms are essential for the normal development and maintenance of tissue-specific gene expression patterns in mammals. The disruption of epigenetic processes can lead to the malicious transformation of cells and altered gene function. Alteration in the heritable epigenetic marks can result in inappropriate activation or inhibition of various signaling pathways and lead to disease states such as cancer. Cancer is one of the major public health problems globally. It is one of the leading causes of death. It was estimated that in 2012, more than 2% new cancer cases occurred globally.

Further, the report states that one challenge in the market is difficulty in finding predictive epigenetic biomarker. A biomarker is a characteristic that is accurately measured and evaluated as an indicator of normal biological processes, pharmacologic responses, or pathogenic processes to a therapeutic intervention. It is any structure, substance, or method that can be measured in the body. It can be a product such as protein after gene expression, which can predict the incidence or outcome of a disease.The use of biomarkers in clinical and basic research as well as in clinical practice has become so ordinary that their presence as primary endpoints in clinical trials is now accepted almost without question.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/global-epigenetics-market

Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- https://www.technavio.com/industries/lab-equipment
Follow us on Twitter @ Technavio

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

LEAVE A REPLY

Please enter your comment!
Please enter your name here